CNSP — CNS Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: CNS Pharmaceuticals Says No Exposure To Silicon Valley Bank Issues
Brief: CNS Pharmaceuticals Continues Momentum In Ongoing Potentially Pivotal Global Trial Evaluating Berubicin For The Treatment Of GBM With First Patient Enrolled In Switzerland
Brief: CNS Pharmaceuticals Announces First Patient Enrolled In Spain In Ongoing Trial Evaluating Berubicin For Treatment Of GBM
Brief: CNS Pharmaceuticals Inc Announces Investigator-Initiated Phase 1B/2 Trial To Be Conducted At The Pomeranian Medical University In Poland
Brief: CNS Pharmaceuticals Appoints Faith Charles As Chair Of Its Board
Brief: CNS Pharmaceuticals Announces Preliminary Results From Ongoing Trial Evaluating Berubicin For Treatment Of Recurrent Glioblastoma Multiforme
Brief: CNS Pharmaceuticals Announces Pricing Of $6.0 Million Public Offering
Brief: Cns Pharmaceuticals Announces Reverse Stock Split
Brief: CNS Pharmaceuticals Reports Third Quarter 2022 Financial Results
CNS Pharma rises on dosing first patient in a global brain cancer trial
Brief: Cns Pharmaceuticals Announces Dosing Of First Patient In Europe/France In Ongoing Trial Evaluating Berubicin For Treatment Of GBM
Brief: CNS Pharmaceuticals Announces Activation Of First Clinical Trial Sites In Europe For Ongoing Potentially Pivotal Global Trial Evaluating Berubicin For The Treatment Of GBM
Brief: CNS Pharmaceuticals reports Q2 results
CNS Pharmaceuticals Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: CNS Pharmaceuticals Urges Shareholders To Vote In Favor Of Proxy Proposals For The Upcoming Annual Meeting Of Shareholders On July 27, 2022
Brief: CNS Receives U.S. FDA Approval For Protocol Amendment To Trial Evaluating Berubicin
CNS Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Cns Pharmaceuticals Reports First Quarter 2022 Financial Results And Provides Corporate Update
CNS Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview